The aim of the meeting is to share and celebrate Liverpool's contribution to blood cancer research across multiple domains, identify new synergies and research opportunities, and map out a way forward that gives all stakeholders a sense of ownership.

TOPICS COVERED

The day starts with a corporate symposium from 9-11am with presentations from national experts in treatment sequencing in CLL and CART cells. There follows a series of presentations summarising Liverpool's research activities and achievements in the following domains: clinical research and associated bioresources (local delivery and national leadership); laboratory research; health data research; and cross-disciplinary research. The day will conclude with a discussion session to gather feedback and ideas that will help to share direction of future blood cancer research in Liverpool.

WHO SHOULD ATTEND?

The event is suitable for anyone with an interest in blood cancer. It should be highlighted that all on-site places have been filled. However, anyone who wants to join the meeting can do so via video link.

SPEAKERS

External (to Liverpool) speakers are Dr Talha Munir (Leeds) and Dr Eleni Tholouli (Manchester). Internal speakers/chairs include: senior academic haematologists (Profs Andy Pettitt and Nagesh Kalakonda); NHS consultant haematologists (Drs Muhammad Saif, Matt Wells, Jeff Smith, Lynny Yung, Steve Hawkins, Nauman Butt, Tom Seddon, Arvind Arumainathan); clinical trainees (Indrani Karpha, Yeong Lim, Andy Ross); research nurse (Jane Tinsley); senior scientists (Prof Joe Slupsky, Dr Mark Glenn; Dr Lihui Wang); non-clinical PhD students (Abigail Clark, Abdulrahman Majrashi); a biobank manager (Dr Melanie Oates); and a research governance manager (Brogan Johnson).

For more information, please contact: [email protected].